Robert Eugene Kristal
CIK: 0001893955
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BRTX
BioRestorative Therapies, Inc.
Officer
Discretionary Trading P&L
Holdings
About Kristal Robert Eugene
Kristal Robert Eugene (SEC CIK 0001893955) files insider reports with the SEC as Chief Financial Officer of BioRestorative Therapies, Inc. (BRTX).
Signal8 holds 1 ownership filing by Kristal Robert Eugene, a Form 4, filed on Feb 19, 2025. Those filings report 1 transaction, the latest on Feb 14, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kristal Robert Eugene's filings is in MELVILLE, NY.
Recent filings by Kristal Robert Eugene
- Feb 14, 2025: Grant or award of BRTX derivative securities (Form 4, code A).
Other insiders filing for BioRestorative Therapies, Inc. (BRTX)
- Randhawa Esha, Director
- Grasso Mika, Director
- Dhaliwal Jatinder, Director
- Field Katharyn, Director
- Silva Francisco, VP of Research and Development
- ALSTODT LANCE, President, CEO, COB